| Name | Title | Contact Details |
|---|
OM1 is a leading health outcomes and registries company focused on the measurement, comparison, and prediction of treatment outcomes. Leveraging big data, standardized outcomes measurement, and artificial intelligence technology, OM1 built the first intelligent data cloud for healthcare, enabling more precise information and better decision making for stakeholders across the healthcare ecosystem.
Medical Asset Management Inc is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 2017, Sift Healthcare is a Milwaukee-based healthcare payments analytics and data science company. Sift`s Payments Intelligence Platform, machine learning integrations and Rev/Track Insights Suite enable healthcare providers and payers to fully leverage their payments data to accelerate insurance reimbursement, improve patient payment strategies and optimize revenue cycle efficiency.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Towson Medical Equipment Co is a Towson, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.